Study Details
Volixibat: A Possible Rare Liver Disease Medication
(IRB#: IRB_00148152)
PBC is a chronic rare liver disease. Volixibat is a potential medication for symptoms of this disease. Scientists and doctors do not know the safety and effectiveness of this drug. Research is needed to learn if it may be approved by the United States Food and Drug Administration (FDA) and then used to improve the health of PBC patients.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes
IRB#: IRB_00148152
PI: Juan Gallegos-Orozco
Department: GASTROENTEROLOGY
Approval Date: 2022-05-25 06:00:00
Specialties: Gastroenterology